The field traces its origins to the 1980s, when Ned Seeman proposed using cross-shaped Holliday junctions as modular building blocks for larger assemblies. By adjusting the sticky ends of these four-arm junctions, researchers could link tiles into increasingly complex two-dimensional patterns, culminating in Winfree’s 1998 demonstration of 2D DNA crystals built from double-crossover tiles. The pivotal breakthrough came in 2006, when Paul Rothemund introduced DNA origami: a long single strand of bacteriophage DNA folded by hundreds of short staple strands into pre-designed shapes of roughly 100 nanometers, from simple triangles to intricate patterns. In 2012, Peng Yin’s group added a third pillar with DNA bricks—short synthetic strands that self-assemble into stable three-dimensional constructs without any long scaffold, each brick functioning as a removable module. Today, complementary strategies such as rolling circle amplification and enzyme-free reactions like hybridization chain reaction and catalytic hairpin assembly allow structural construction and signal amplification to proceed simultaneously under mild, isothermal conditions.

What makes DNA nanostructures so attractive for fighting pathogens is a constellation of biophysical properties. Their geometry can be engineered with near-atomic precision, and that geometry directly governs biological behavior. Tetrahedral DNA nanostructures (TDNs) decorated on nanoparticle cores mimic the spiky architecture of coronaviruses, boosting small interfering RNA delivery efficiency from roughly 20 percent to 95 percent. The structures enter cells through caveolin-dependent and macropinocytosis pathways despite their negative charge, with size, shape, and rigidity each modulating uptake; medium-sized, compact, three-dimensional particles generally perform best. They also penetrate remarkable biological barriers: structures of 75 nanometers or less can reach the dermis, TDNs traverse up to 450 micrometers of skin, and the structures diffuse into bacterial biofilms—the dense, antibiotic-resistant fortresses that thwart conventional therapies.

Equally striking is their antioxidant chemistry. DNA origami scavenges singlet oxygen approximately 50,000 times more efficiently than double-stranded DNA, because folded architectures concentrate guanine active sites at high density. TDNs bind the antioxidant enzyme copper-zinc superoxide dismutase with extraordinary affinity, a dissociation constant of 7.59 × 10⁻¹² molar, and can dampen oxidative stress through the Nrf2/HO-1, MAPK, and NF-κB signaling pathways. Combined with low cytotoxicity below 250 nanomolar concentrations, negligible effects on platelets and red blood cells, high drug-loading capacity through intercalation, groove binding, electrostatic adsorption, or sequence hybridization, and rapid renal clearance of small constructs, these features position DNA nanostructures as unusually benign yet capable nanocarriers.

On the diagnostic front, the review documents detection limits that routinely rival or surpass polymerase chain reaction and ELISA. DNA walkers—dynamic structures that move along programmed tracks—have been coupled with electrochemical readouts to detect Staphylococcus aureus at just 9 colony-forming units per milliliter. A polymethylene blue nanoparticle sensor built on dumbbell hybridization chain reaction pushed S. aureus detection down to a single cell per milliliter in human serum and food samples. Dual-mode photoelectrochemical and surface-enhanced Raman spectroscopy platforms now allow hierarchical screening and confirmation in complex matrices such as fruit juices, while cyclic DNA nanostructure gold nanoparticle tags combined with cascade primer exchange reactions detect E. coli O157:H7 at 1.91 colony-forming units per milliliter with recoveries between roughly 88 and 108 percent in real samples.

Against viruses, tetrahedral frameworks have proven especially powerful. TDN-supported field-effect transistors detect SARS-CoV-2 nucleic acid in about 80 seconds without extraction or amplification, reaching limits of one to two copies per 100 microliters of clinical sample. DNA nanobait structures identify multiple respiratory viruses simultaneously at the single-molecule level without reverse transcription or pre-amplification, and a bipedal DNA walker paired with strand displacement amplification achieves attomolar sensitivity with single-base resolution in 15 minutes. Beyond detection, spatially patterned icosahedral DNA nanocages carrying up to 30 neutralizing aptamers block the SARS-CoV-2 spike–ACE2 interaction across variants including Omicron, and cone-shaped DNA origami traps physically engulf pleomorphic virus particles larger than 100 nanometers, from influenza A to Zika and chikungunya. Star-shaped designer DNA architectures display aptamers in patterns that precisely match dengue virus surface antigens, functioning as both sensor and inhibitor.

Therapeutic applications extend deep into antibacterial medicine. TDNs delivering the antimicrobial peptide GL13K enhanced activity against E. coli and restored efficacy against Porphyromonas gingivalis, and an injectable thermosensitive hydrogel system co-delivering GL13K with C/EBPα small activating RNA is being developed for periodontitis, offering anti-inflammatory and osteogenic benefits alongside antibacterial action. TDN–clindamycin complexes lowered the minimum inhibitory concentration eightfold against methicillin-resistant S. aureus in infected bone defect models. DNA origami platforms carrying lysozyme within five wells and 14 targeting aptamers homed in on Bacillus subtilis and E. coli, while a bactericidal origami co-loading G4/hemin DNAzyme and levofloxacin breached bacterial membranes and accelerated infected wound healing in vivo. Antisense oligonucleotide delivery by TDNs has silenced biofilm-forming genes in Streptococcus mutans, and six-helix bundle structures co-delivering antisense RNA with silver ions showed synergistic killing of both gram-positive and gram-negative bacteria.

The technology is not without serious bottlenecks. DNA nanostructures depend on cations such as magnesium to neutralize electrostatic repulsion, so physiological media can trigger disassembly, and nucleases degrade unprotected structures rapidly. The hundreds of custom oligonucleotides required for origami are expensive, and laboratory fabrication resists scale-up to good manufacturing practice standards. Regulatory pathways remain ambiguous, batch-to-batch consistency is difficult to guarantee, and assembly byproducts arising from kinetic traps and thermodynamic competition depress yields. Pathogen-specific obstacles compound these challenges: biofilm extracellular matrices impede penetration even though TDNs achieve 44-fold stronger fluorescence at 20-micrometer biofilm depth than linear structures; RNA viruses mutate rapidly enough to escape single-target therapeutics, though multivalent, multi-epitope DNA scaffolds offer a hedge; and fungal cell walls of bewildering structural variability limit drug access, even as TDNs improve delivery of the antifungal peptide Histatin 5 against Candida albicans.

The outlook nevertheless points toward integration. The review’s authors propose stability benchmarks—structures retaining more than 80 percent integrity after 24 hours in human serum—alongside xenonucleic acid backbones, disulfide crosslinking, and oligolysine-PEG coatings to harden constructs against serum and nucleases. Double-blind validation across at least 500 clinical samples is framed as the gateway to diagnostic approval, while microfluidic chips, lyophilized paper-based formats, and artificial intelligence-assisted design promise point-of-care deployment by non-specialists. On the preventive side, DNA origami vaccine scaffolds have orchestrated antigen and CpG adjuvant spacing to elicit durable immune responses, DNA–RNA hybrid origami shows ribonuclease resistance suitable for mRNA vaccines, and inhalable DNA nano-adjuvants have activated lung-resident memory immunity against pneumonic plague in mice. Perhaps most compelling is the prospect of convergent platforms: single DNA nanostructures that detect an infection, deliver the therapeutic payload, and prime immunity—all from the same molecule that carries life’s code.

Subject of Research: Applications of DNA nanostructures in the detection, treatment, and prevention of pathogenic microorganisms

Article Title: Advances in DNA nanostructures for pathogenic microorganisms

Article References: Han, X., Zhang, J., Pang, S., Wei, G., Niu, J., Lu, Y., & Xi, J. (2026). Advances in DNA nanostructures for pathogenic microorganisms. Materials Today Bio, 40, Article 103591. https://doi.org/10.1016/j.mtbio.2026.103591

Image Credits: AI Generated

DOI: Not provided

Keywords: DNA nanostructures, DNA origami, tetrahedral DNA nanostructures, pathogen detection, antibacterial therapy, antiviral therapy, biosensors, drug delivery, biofilms, SARS-CoV-2, CRISPR diagnostics, nanomedicine

Central to this paradigm shift is the ability to seamlessly marry biological functionalities with engineered physical components. Microbes, traditionally viewed as isolated biological entities, are now being embedded within microfluidic architectures where fluids containing substrates or analytes can be precisely manipulated under electronic control. These engineered microbes or cell-free systems serve as living sensors or actuators, responding dynamically to environmental triggers. The intimate integration with electronics affords enhanced signal transduction, data acquisition, and real-time feedback loops, effectively turning biological systems into cyber-physical entities. This hybridization overcomes limitations inherent in purely biological or purely electronic sensors, such as slow response times, limited sensitivity, or inadequate specificity.

Delving into the design principles underlying these hybrid systems reveals a complex interplay of biological engineering, materials science, electrical engineering, and computational modeling. Researchers must consider factors such as biocompatibility, microenvironment control, communication interfaces, and energy supply. For instance, the microfluidic setup not only serves as a conduit but is often engineered to establish gradients, isolate single cells, or create high-throughput screening arrays, tailoring the biological response to the specific application. Meanwhile, the electronic elements must maintain sensitivity and selectivity to biological signals, sometimes requiring novel nanoscale transducers or bioelectronic interfaces, ensuring that signals from biological processes are accurately captured and digitized.

One of the transformative impacts of these hybrid systems lies in healthcare. Engineered bacteria, coupled with electronics, are being explored for in situ diagnostics, capable of detecting markers of disease directly within the human body or in biopsied samples. The integration of microfluidics enables the handling of tiny volumes, facilitating rapid assays with minimal invasiveness. This could herald a new era of personalized medicine, where biohybrid devices continuously monitor physiological states, detect pathogens or metabolic imbalances, and even trigger the release of therapeutic agents in real-time. Such closed-loop systems exemplify the potential of cyber-biological integration to transcend traditional boundaries in diagnostics and therapy.

Beyond healthcare, environmental monitoring stands to benefit enormously from these advances. Microbial consortia engineered to recognize pollutants can be embedded within microfluidic devices deployed in natural habitats, waterways, or industrial effluents. Coupled with electronic readouts, these devices can provide continuous, remote monitoring of environmental health at molecular specificity. The integration allows for early detection of contamination, facilitating timely interventions. Moreover, these engineered systems can be adapted for bioremediation, sensing and degrading environmental toxins while reporting the progress electronically, providing a dual function rarely achievable by conventional methods.

Agricultural applications present another fertile ground for the deployment of hybrid engineered biological systems. The ability to monitor soil health, detect pathogen presence, or gauge nutrient levels through embedded biosensors integrated with microfluidics and electronics could revolutionize precision farming. Such systems could provide farmers with actionable data streams, enabling optimized irrigation, fertilization, and pest management practices that enhance yields while reducing environmental impact. The scalability of microfluidic and electronic components ensures that these solutions can be adapted for use in varied agricultural landscapes, from smallholder farms to industrial-scale operations.

While the promise of these hybrid engineered systems is immense, their design and deployment are accompanied by significant challenges. Critical among these is the need to maintain biosafety and biocontainment. The living components must be securely encapsulated within devices to prevent unintended environmental release while ensuring their functional longevity. Moreover, integrating living systems with inorganic electronics requires harmonizing disparate physical and chemical environments. Issues like biofouling, electronic noise, stability of biological components, and cross-talk between the biological and electronic domains must be managed through innovative materials, coatings, and device architectures.

Another emerging and essential consideration is cybersecurity within biohybrid systems. As these engineered biological devices become more interconnected and reliant on digital infrastructure for data transmission and control, they become potentially vulnerable to cyberattacks. Malicious interference could compromise both data integrity and biological activity, posing risks to health, environment, and security. Proactively developing cyber-secure biological systems involves incorporating encryption, secure data channels, tamper sensors, and fail-safe mechanisms, elevating these devices beyond conventional cyber-physical security frameworks into the realm of living, responsive organisms.

The need for a cohesive framework to guide the design and optimization of hybrid engineered biological systems is increasingly recognized. Researchers are calling for classification schemas that delineate system components, functional modes, biological interfaces, and application contexts. Such frameworks aid in harmonizing terminology, benchmarking performance metrics, and fostering interoperability between device components developed across disparate disciplines. By systematically categorizing design choices, biological platforms, and electronic interfaces, the field can accelerate innovation while mitigating redundancy and facilitating technology transfer.

To capture the rapid developments and encourage collaborative progress, several initiatives have introduced dynamic, interactive platforms that serve as “living roadmaps” for the field. These online resources aggregate the latest research breakthroughs, technology trends, design templates, and community-contributed updates. They empower researchers to track emerging methodologies, identify gaps, and contribute insights, thereby catalyzing accelerated collective learning. Such living databases are integral to a community-driven scientific ecosystem where the boundary between biology, electronics, and information technology is increasingly blurred.

At the heart of these hybrid systems are engineered biological components, such as microbes rewired through synthetic biology or cell-free DNA constructs designed for molecular recognition. Synthetic biology techniques allow for the modular design and precise tuning of genetic circuits, enabling living sensors to respond with calibrated outputs. Meanwhile, cell-free systems boast advantages in safety and programmability, as they eschew living cells while retaining functional biomolecules capable of sensing and computation. Embedding these components within microfluidic systems enhances control over chemical gradients, reaction kinetics, and multiplexing capabilities, thereby expanding the functional repertoire of engineered biosystems.

Integration with electronics extends beyond signal detection to encompass actuation and control. Advanced bioelectronic interfaces enable bidirectional communication, where biological states influence electronic controls, and electronic signals modulate biological behavior. This intertwining allows for responsive systems capable of adaptation and learning, pointing toward future biohybrid devices with autonomous functions. For example, electronic stimuli could synchronize gene expression rhythms or initiate on-demand metabolic switches, broadening the scope of synthetic biology applications.

The microfluidic dimension adds unparalleled versatility, facilitating complex sample manipulation and real-time monitoring within compact form factors. Innovations in microfabrication have made it possible to create intricate channels, valves, and compartments that faithfully mimic biological microenvironments or scale-up parallel assays. The miniaturization and portability conferred by microfluidics pave the way toward point-of-care diagnostics, wearable biosensors, and field-deployable environmental monitors, democratizing access to sophisticated biotechnologies.

Future trajectories in the domain envisage the refinement of hybrid engineered biological systems into fully cybersecure, autonomous platforms embedded in the Internet of Things (IoT). By harnessing cloud computing, machine learning, and encrypted communication, these devices could form decentralized networks delivering continuous, real-time bioanalytics at a global scale. Such integration promises transformative impacts on public health surveillance, environmental stewardship, and sustainable agriculture, driving a new industrial biotechnology epoch guided by interconnected, intelligent biological machines.

In conclusion, the marriage of electronics, microfluidics, and engineered biological systems signifies a bold stride in bioengineering, offering unprecedented capabilities and applications. Overcoming design challenges and forging robust cyberbiosecurity frameworks are critical to unlocking this technology’s full potential. The ongoing creation of classification frameworks and dynamic living roadmaps illustrates the field’s commitment to collaborative progress and transparency. As the hybrid bioelectronic frontier continues to evolve at breakneck speed, it holds the key to next-generation solutions for some of humanity’s most pressing challenges across health, environment, and agriculture.

Subject of Research: Hybrid engineered biological systems integrating electronics and microfluidics with engineered biological components for sensing, actuation, and reporting in biological environments.

Article Title: Improving engineered biological systems with electronics and microfluidics.

Article References:

Yazicigil, R.T., Bali, A., Caygara, D. et al. Improving engineered biological systems with electronics and microfluidics.
Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02709-6

Image Credits: AI Generated